Brokerages Set Humana Inc. (NYSE:HUM) PT at $486.26

Humana Inc. (NYSE:HUM) has received a consensus recommendation of “Buy” from the eighteen brokerages that are covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 12-month target price among brokers that have covered the stock in the last year is $486.92.

HUM has been the subject of several analyst reports. Seaport Global Securities initiated coverage on Humana in a report on Friday, July 9th. They set a “neutral” rating and a $455.65 target price for the company. Cowen started coverage on Humana in a report on Thursday, September 9th. They set an “outperform” rating and a $479.00 target price for the company. Barclays started coverage on Humana in a research report on Thursday, September 9th. They set an “overweight” rating and a $500.00 price target on the stock. Zacks Investment Research raised Humana from a “hold” rating to a “buy” rating and set a $490.00 price target on the stock in a research report on Friday, July 16th. Finally, Seaport Res Ptn reissued a “neutral” rating on shares of Humana in a research report on Friday, July 9th.

In other Humana news, Director David A. Jr/Ky Jones sold 4,800 shares of the company’s stock in a transaction dated Thursday, September 16th. The stock was sold at an average price of $401.00, for a total value of $1,924,800.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 0.40% of the company’s stock.

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. ProShare Advisors LLC boosted its stake in shares of Humana by 19.2% during the 2nd quarter. ProShare Advisors LLC now owns 22,689 shares of the insurance provider’s stock worth $10,045,000 after acquiring an additional 3,651 shares in the last quarter. Canada Pension Plan Investment Board boosted its stake in shares of Humana by 34.6% during the 1st quarter. Canada Pension Plan Investment Board now owns 178,778 shares of the insurance provider’s stock worth $74,953,000 after acquiring an additional 45,992 shares in the last quarter. Public Sector Pension Investment Board boosted its stake in shares of Humana by 65.9% during the 2nd quarter. Public Sector Pension Investment Board now owns 20,224 shares of the insurance provider’s stock worth $8,954,000 after acquiring an additional 8,030 shares in the last quarter. CCLA Investment Management Ltd boosted its stake in shares of Humana by 0.6% during the 2nd quarter. CCLA Investment Management Ltd now owns 197,781 shares of the insurance provider’s stock worth $87,542,000 after acquiring an additional 1,169 shares in the last quarter. Finally, Weiss Multi Strategy Advisers LLC boosted its stake in shares of Humana by 5.3% during the 1st quarter. Weiss Multi Strategy Advisers LLC now owns 9,979 shares of the insurance provider’s stock worth $4,184,000 after acquiring an additional 505 shares in the last quarter. Institutional investors own 91.85% of the company’s stock.

Shares of NYSE HUM traded up $13.15 during mid-day trading on Monday, hitting $433.84. 20,053 shares of the company traded hands, compared to its average volume of 896,439. Humana has a 1 year low of $370.22 and a 1 year high of $475.44. The stock has a market capitalization of $55.75 billion, a price-to-earnings ratio of 22.83, a PEG ratio of 1.42 and a beta of 0.89. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 0.41. The business has a 50 day moving average of $406.80 and a two-hundred day moving average of $428.72.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, July 28th. The insurance provider reported $6.89 EPS for the quarter, beating the consensus estimate of $6.86 by $0.03. Humana had a return on equity of 13.62% and a net margin of 3.09%. The business had revenue of $20.65 billion during the quarter, compared to the consensus estimate of $20.51 billion. As a group, research analysts anticipate that Humana will post 21.49 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, October 29th. Shareholders of record on Thursday, September 30th will be given a $0.70 dividend. This represents a $2.80 annualized dividend and a yield of 0.65%. The ex-dividend date is Wednesday, September 29th. Humana’s payout ratio is currently 14.93%.

Humana Company Profile

Humana Inc engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty and Healthcare Services. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental benefit plans such as Medicare, and State-based Medicaid contracts.

Recommended Story: How To Calculate Debt-to-Equity Ratio

Analyst Recommendations for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.